Inventor · disambiguated record
Niall Andrew Anderson
Also filed as: ANDERSON NIALL · ANDERSON NIALL ANDREW
14 granted patents·4 pending applications·44 citations·filing 2010–2022
90Inventor score
Top patents by PatentIndex Score
18 records- 0191US10513517B2Naphthyridine derivatives as alpha V beta 6 integrin antagonists for the treatment of E.G. fibrotic diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Dec 24, 2019·11 cites·3 claims
- 0286US10899716B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2020·Granted Jan 26, 2021·2 cites·2 claims
- 0385US10590085B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2016·Granted Mar 17, 2020·3 cites·31 claims
- 0485US10023568B2Naphthyridine derivatives useful as αvβ6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2014·Granted Jul 17, 2018·5 cites·39 claims
- 0584US10450312B2Naphthyridine derivatives useful as alpha-V-beta-6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Oct 22, 2019·3 cites·82 claims
- 0684US10144733B2Naphthyridine derivatives as alpha v beta 6 integrin antagonists for the treatment of E.G. fibrotic diseasesGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Dec 4, 2018·5 cites·13 claims
- 0783US9956209B2Compounds αv β6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted May 1, 2018·4 cites·10 claims
- 0882US10000489B2Compounds αvβ6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Jun 19, 2018·5 cites·17 claims
- 0978US10487080B2Naphthyridines as integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Nov 26, 2019·3 cites·23 claims
- 1076US10004724B2Compounds alpha v beta 6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2015·Granted Jun 26, 2018·2 cites·17 claims
- 1175US2023120185A1Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2022·Application pending·0 cites
- 1274US10342783B2Compounds αvβ6 integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2018·Granted Jul 9, 2019·1 cites·38 claims
- 1369US11485710B2Heterocyclic amides as kinase inhibitorsGLAXOSMITHKLINE IP DEV LTD·Filed 2021·Granted Nov 1, 2022·0 cites·30 claims
- 1461US10793559B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2019·Granted Oct 6, 2020·0 cites·3 claims
- 1556US2019275016A1NOVEL COMPOUNDS avB6 INTEGRIN ANTAGONISTS.GLAXOSMITHKLINE IP DEV LTD·Filed 2019·Application pending·0 cites
- 1653US10457674B2Chemical compoundsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Granted Oct 29, 2019·0 cites·9 claims
- 1743US2021206758A1Naphthyridines as integrin antagonistsGLAXOSMITHKLINE IP DEV LTD·Filed 2017·Application pending·0 cites
- 1831US2012142668A1Cathepsin c inhibitorsANDERSON NIALL·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Niall Andrew Anderson files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →